Oxford University developed off-the-shelf artificial dermis, for deep skin-loss wounds. Re-growing skin scarlessly will save lives and transform life-long outcomes for patients. Raising £350k pre-seed SEIS/EIS to co-fund CE/FDA regulatory testing.
Target |
£350,000
|
Minimum |
£10,000
|
Invested |
£50,000
|
Previous Rounds | n/a |
Stage | Finished Product |
Investor Role | Monthly Involvement |
Sign up now to gain full access to pitches and investor profiles
global:publish_msg_immediate
global:publish_msg
You have passed the test and you may continue your with your investment.